Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 | Orally Administered SIRTl Activator SRT501 is Neuroprotective for Retinal Ganglion Cells and Suppresses Neurological Dysfunction in a Mouse Model of Multiple Sclerosis | Kenneth S. Shindler; Elvira Ventura; Peter Elliott; A.M. Rostami | NANOS 2008: Platform Session I | |
2 | Retinal Ganglion Cell Loss in a Mouse Model of Optic Neuritis | Francois Evoy, MD; Julie Prévost; Marie-Ève Arsenault | ||
3 | Sirtuin-Activating Compounds Prevent Retinal Ganglion Cell Loss During Acute Optic Neuritis | Kenneth S. Shindler; Abdolmohamad M. Rostami | NANOS 2006: Scientific Platform Presentations (Session I) |